Symmetry Medical Appoints Ajey Atre President of Symmetry Surgical

WARSAW, Ind., July 30, 2013 (GLOBE NEWSWIRE) -- Symmetry Medical Inc. (NYSE:SMA), a leading global source of innovative medical device solutions, including surgical instruments, orthopedic implants, and sterilization cases and trays, announced today that it has appointed Ajey Atre to the position of President of its subsidiary, Symmetry Surgical, Inc., effective August 12, 2013. Mr. Atre will be responsible for leading the global Symmetry Surgical business and will be based at the Symmetry Surgical headquarters in Nashville, TN. He will report to Thomas J. Sullivan, President and Chief Executive Officer of Symmetry Medical.

Mr. Sullivan stated, "Ajey brings nearly twenty years of experience in medical devices to Symmetry Surgical, including relevant experience as a senior leader for a global business. He has a wealth of general management skills that will benefit Symmetry Surgical, including the ability to drive cross functional teams and focus on customer satisfaction. We believe he is the right leader for the business at this critical stage in the Company's development. On behalf of the management team I would like to welcome Ajey to the Symmetry team."

For the past five years, Mr. Atre was General Manager of Zimmer's Trabecular Metal Technologies business, with responsibility for strategic planning, new product development, market development, global revenue expansion, surgeon education, quality and regulatory compliance, operational excellence, and employee engagement. Mr. Atre's experience also includes serving as Vice President Global Supply Chain and Operations at DJO Global's Aircast Division. At DJO, his experience included Sales, Engineering and Operations positions. Mr. Atre holds a Master's of Science in Biomechanical Engineering from the New Jersey Institute of Technology and a Bachelor's of Science in Mechanical Engineering from the College of Engineering, Pune, in India. He earned a Master's in Business Administration from the Harvard Business School.

About Symmetry Surgical

Symmetry Surgical is dedicated to developing quality surgical instruments that meet the needs of clinicians and help improve the lives of patients. Our portfolio brings together the product lines of Specialty Surgical Instrumentation (SSi), Olsen Medical and the recently acquired surgical instruments division Codman & Shurtleff, Inc. Our well-known brands include BOOKWALTER®, GREENBERG™, RILEY™, OLSEN™, ULTRA™, QUAD-LOCK™, FLASHPAK™, RAPIDCLEAN®, OPTI-LENGTH®, CLASSIC® and CLASSIC PLUS®. Headquartered in Nashville, Symmetry Surgical is a wholly owned subsidiary of Symmetry Medical Inc (NYSE:SMA).

About Symmetry Medical Inc.

Symmetry Medical Inc. is a leading global source of innovative medical device solutions, including surgical instruments, orthopedic implants, and sterilization cases and trays. The Company's thousands of Teammates provide design, development and worldwide production capabilities for these products to customers in the orthopedic industry, other medical device markets, and specialized non-healthcare markets. Symmetry's trusted reputation and brands, broad Intellectual Property portfolio and commitment to innovation enable it to collaborate with hundreds of global medical device manufacturers as well as thousands of hospitals to provide solutions for today's needs and tomorrow's growth.

Forward-Looking Statements

Statements in the press release regarding Symmetry Medical Inc.'s business which are not historical facts may be "forward-looking statements" that involve risks and uncertainties, within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are predictive in nature and are frequently identified by the use of terms such as "may," "might," "will," "should," "expect," "believe," "anticipate," "plan," "estimate," "intend," and similar words indicating possible future expectations, events or actions. Such predictive statements are not guarantees of future performance, and actual outcomes and results could differ materially from our current expectations. We refer you to the "Risk Factors" and "Forward Looking-Statements" sections in the Company's most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission as well as the Company's other filings with the SEC, which are available on the SEC's Web site at www.sec.gov.

CONTACT: Symmetry Medical Inc. Fred L. Hite Senior Vice President Chief Financial Officer (574) 371-2218 Investors: The Ruth Group Zack Kubow (646) 536-7020 zkubow@theruthgroup.comSource:Symmetry Medical Inc.